Related Experiment Video
Updated: Jul 16, 2026

A High-Fidelity Porcine Model of Orthotopic Heart Transplantation Following Donation after Circulatory Death
Published on: June 6, 2025
Donor heart selection: the outcome of "unacceptable" donors
Noman H Khasati1, Ali Machaal, Jim Barnard
1Cardiothoracic Surgery Department, Wythenshawe Hospital, Manchester, UK. nkhasati@yahoo.com
Insights
Donor hearts medically unsuitable at one UK center can be safely transplanted at others, expanding the organ pool. This study found no significant differences in outcomes for recipients of these hearts compared to standard donors.
Area of Science:
- Cardiovascular Surgery
- Transplantation Medicine
- Organ Donation
Background:
- Declining numbers of suitable donor hearts necessitate exploring previously unacceptable donors.
- In the UK, donor hearts declined by one center may be offered to others.
- This study evaluates outcomes of hearts deemed medically unsuitable by one center but transplanted by another.
Purpose of the Study:
- To assess the safety and efficacy of transplanting donor hearts initially declined on medical grounds.
- To determine if utilizing these hearts impacts recipient outcomes compared to standard donor hearts.
- To evaluate the potential of expanding the donor heart pool through the use of previously rejected organs.
Main Methods:
- A multi-center study comparing 93 donor hearts (Group A) transplanted after initial medical unsuitability with 723 standard donor hearts (Group B) transplanted in the UK (April 1998-March 2003).
- Data sourced from the UK transplant database.
- Comparative analysis using SPSS 11.5 for Windows.
Main Results:
- Recipient characteristics were similar between Group A and Group B.
- No significant differences observed in 30-day post-operative mortality, ICU/hospital stay, or cardiac cause of death.
- Kaplan-Meier survival curves showed no significant difference in long-term survival (Log Rank test = 0.30).
Conclusions:
- Donor hearts declined on medical grounds by one center can be safely transplanted and should be considered for national allocation.
- The utilization of these hearts effectively expands the scarce donor pool.
- There is no apparent justification for withholding this additional organ source from recipients.
Background:
The decline in the number of suitable donor hearts has led to an increasing interest in the use of previously unacceptable donors. In the United Kingdom, if one centre declines a donor heart on medical grounds it may be offered to other centres. This multi-centre study aimed to evaluate the outcome of recipients of donor hearts considered medically unsuitable for transplantation by one centre that were used in other centres.
Methods:
Between April 1998 and March 2003, ninety-three donor hearts (group A) were transplanted, after being considered medically unsuitable for transplantation by another centre. During the same period, 723 hearts (group B) were transplanted in the UK using donors not previously rejected. Data on the donors and recipients was obtained from the UK transplant database. Comparative analysis on the two groups was performed using SPSS 11.5 for Windows.
Results:
The characteristics of recipients were similar in both groups. The main reasons for refusal of hearts are listed below. In most cases there was more than one reason for refusing the donor heart. We did not find significant differences in the post-operative mortality (up to 30 days), ICU and hospital stay and cardiac cause of death between the two groups. Kaplan-Meier survival curves showed no significant difference in the long-term survival, with Log Rank test = 0.30.
Conclusion:
This study demonstrates that some hearts declined on medical grounds by one centre can safely be transplanted and should be offered out nationally. The use of these hearts was useful to expand the scarce donor pool and there does not seem to be a justification for denying recipients this extra source of organs.
Related Concept Videos
Kidney Transplant I: Introduction
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

